Testing A Noninferiority Hypothesis: What to Anticipate when the Adverse Event is Rare

Author： McEvoy Bradley W.   Frimpong Eric Y.  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.1, 2013-01, pp. : 122-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decision-Theoretic Views on Simultaneous Testing of Superiority and Noninferiority

By Koyama Tatsuki  

Journal of Biopharmaceutical Statistics, Vol. 15, Iss. 6, 2005-01 ,pp. : 943-955

Taylor & Francis Ltd

Access to resources Recommend Favorite

Noninferiority Testing Beyond Simple Two-Sample Comparison

By Tsong Yi   Chen Wen-Jen  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 2, 2007-03 ,pp. : 289-308

Taylor & Francis Ltd

Access to resources Recommend Favorite

Manufacturer's Drug Interaction and Postmarketing Adverse Event Data: What Are Appropriate Uses?

By Kraft W.K.   Waldman S.A.  

Drug Safety, Vol. 24, Iss. 9, 2001-01 ,pp. : 637-643

Adis International

Access to resources Recommend Favorite

A More Powerful Test Based on Ratio Distribution for Retention Noninferiority Hypothesis

By Deng Ling   Chen Gang  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 346-360

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Ratio Test in Active Control Non-Inferiority Trials with a Time-to-Event Endpoint

By Wang Yong-Cheng  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 2, 2006-03 ,pp. : 151-164

Taylor & Francis Ltd

Access to resources Recommend Favorite